You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage III verrucous carcinoma of the larynx

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell

Terminated
Has Results
  • Stage III Squamous Cell Carcinoma of the Hypopharynx
  • +11 more
  • cetuximab
  • +3 more
  • Newark, New Jersey
    New Jersey Medical School
Apr 19, 2021

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • KEYTRUDA®
  • (no location specified)
Nov 17, 2023

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
Has Results
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA

Withdrawn
  • Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
  • +6 more
  • hypofractionated radiation therapy
  • +3 more
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell

Terminated
Has Results
  • Stage III Squamous Cell Carcinoma of the Hypopharynx
  • +11 more
  • erlotinib hydrochloride
  • +10 more
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
May 6, 2020

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage 0

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +57 more
  • placebo
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 18, 2020

Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

Not yet recruiting
  • Papillary Renal Cell Carcinoma
  • (no location specified)
Nov 24, 2023

Renal Cell Carcinoma Trial (Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Sep 11, 2023

Neck Cancer Trial in Moscow (Pembrolizumab)

Recruiting
  • Neck Cancer
  • Moscow, Russian Federation
  • +2 more
Sep 21, 2022

Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • without concurrent cisplatin chemotherapy
  • with concurrent cisplatin chemotherapy
  • Fuzhou, Fujian, China
    Department of radiation oncology, Fujian cancer hospital
Oct 18, 2023

Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (Nimotuzumab, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 3, 2022

Glottic Carcinoma Trial in Dallas (Radiation therapy)

Active, not recruiting
  • Glottic Carcinoma
  • Radiation therapy
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Feb 10, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (mobile platform or not mobile platform)

Recruiting
  • Nasopharyngeal Carcinoma
  • mobile platform or not mobile platform
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Apr 17, 2023

NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Sugemalimab and Chemotherapy
  • Changsha, China
    Hunan Cancer Hospital
Jul 7, 2023

NSCLC Trial in Beijing

Recruiting
  • NSCLC
    • Beijing, China
      Yuyan Wang
    Oct 10, 2023

    Acute Side Effects In Stage III NSCLC With Definitive CRT

    Completed
    • Non-small Cell Lung Cancer Stage III
      • Ankara, Turkey
        Ankara University Medicine School Radiation Oncology
      Aug 22, 2023

      Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)

      Active, not recruiting
      • Laryngeal Cancer Stage II
      • +3 more
      • Amsterdam, Netherlands
        The Netherlands Cancer Institute
      Sep 27, 2022

      Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV, Merkel Cell Carcinoma Trial (IFx-Hu2.0)

      Available
      • Cutaneous Melanoma, Stage III
      • +3 more
      • IFx-Hu2.0
      • (no location specified)
      Aug 5, 2022

      Active, not recruiting
      • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
      • +8 more
      • Cetuximab
      • +3 more
      • Pittsburgh, Pennsylvania
        University of Pittsburgh Cancer Institute (UPCI)
      Jan 26, 2023

      NSCLC Trial (Atezolizumab, Tiragolumab)

      Not yet recruiting
      • NSCLC
      • (no location specified)
      Apr 5, 2023

      Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, Anatomic Stage III Breast Cancer Trial in United States

      Not yet recruiting
      • Anatomic Stage I Breast Cancer
      • +3 more
      • Endocrine Therapy
      • +7 more
      • Atlanta, Georgia
      • +4 more
      Jun 15, 2023

      Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II Trial in Australia (Avelumab, Placebo)

      Recruiting
      • Merkel Cell Carcinoma
      • +5 more
      • Port Macquarie, New South Wales, Australia
      • +17 more
      Aug 30, 2022

      Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

      Not yet recruiting
      • Lung Cancer, Nonsmall Cell
      • Lung Cancer Stage III
      • Nivolumab and Chemotherapy
      • +3 more
      • (no location specified)
      Aug 15, 2023